NotesFAQContact Us
Collection
Advanced
Search Tips
Showing all 6 results Save | Export
Peer reviewed Peer reviewed
Direct linkDirect link
Smith, Elizabeth; Hedge, Craig; Jarrold, Christopher – American Journal on Intellectual and Developmental Disabilities, 2019
Executive function (EF) decline is a consistent early sign of Alzheimer's disease (AD) among adults with Down syndrome (DS), which means that baseline measures of EF for individuals with DS are vital to allow detection of meaningful decline. We developed a framework to extract measures of three core components of EF (memory updating, inhibitory,…
Descriptors: Executive Function, Down Syndrome, Identification, Clinical Diagnosis
Peer reviewed Peer reviewed
Direct linkDirect link
Ball, S. L.; Holland, A. J.; Watson, P. C.; Huppert, F. A. – Journal of Intellectual Disability Research, 2010
Background: Recent research has suggested a specific impairment in frontal-lobe functioning in the preclinical stages of Alzheimer's disease (AD) in people with Down's syndrome (DS), characterised by prominent changes in personality or behaviour. The aim of the current paper is to explore whether particular kinds of change (namely executive…
Descriptors: Mental Retardation, Alzheimers Disease, Diseases, Personality
Peer reviewed Peer reviewed
Direct linkDirect link
Krinsky-McHale, Sharon J.; Devenny, Darlynne A.; Kittler, Phyllis; Silverman, Wayne – American Journal on Mental Retardation, 2008
Adults with Down syndrome and early stage Alzheimer's disease showed decline in their ability to selectively attend to stimuli in a multitrial cancellation task. They also showed variability in their performance over the test trials, whereas healthy participants showed stability. These changes in performance were observed approximately 2 years…
Descriptors: Alzheimers Disease, Dementia, Attention Span, Down Syndrome
Peer reviewed Peer reviewed
Direct linkDirect link
Yoo, J. Helen; Valdovinos, Maria G.; Williams, Dean C. – Journal of Autism and Developmental Disorders, 2007
This review discusses the laboratory and clinical research supporting the rationale for the efficacy of donepezil (Aricept[R] USA) in enhancing cognition in autism, Alzheimer disease, Down syndrome, traumatic brain injury, Attention Deficit Hyperactivity Disorder (ADHD), and schizophrenia. While preliminary animal models have shown effective,…
Descriptors: Schizophrenia, Autism, Alzheimers Disease, Diseases
Peer reviewed Peer reviewed
Direct linkDirect link
Kittler, P.; Krinsky-McHale, S. J.; Devenny, D. A. – Journal of Intellectual Disability Research, 2006
Background: Verbal intrusion errors are irrelevant responses made in the course of verbal memory retrieval or language production that have been associated with disruption of executive functions and the prefrontal cortex. They have been observed to occur more frequently both with normal aging and with neurodegenerative diseases such as Alzheimer's…
Descriptors: Down Syndrome, Semantics, Intervals, Word Lists
Peer reviewed Peer reviewed
Direct linkDirect link
Sano, Mary; Aisen, Paul S.; Dalton, Arthur J.; Andrews, Howard F.; Tsai, Wei-Yann – Journal of Policy and Practice in Intellectual Disabilities, 2005
A major challenge to developing therapeutic interventions for cognitive loss and dementia in aging individuals with Down syndrome (DS) is the selection of appropriate outcome measures. This report describes the adaptation of the Brief Praxis Test (a nonverbal cognitive test) as a primary outcome measure, as well as the selection of secondary…
Descriptors: Mental Retardation, Alzheimers Disease, Dementia, Down Syndrome